Clinical Characteristics of Korean Patients with Youth-Onset Type 2 Diabetes Mellitus in Remission.

BACKGROUND

Improving β-cell function can lead to remission in some patients with type 2 diabetes mellitus (T2DM). However, research on pharmacotherapy-induced remission in youth-onset T2DM remains scarce. Our study aimed to identify the clinical characteristics of pediatric patients who experience remission.

METHODS

We retrospectively reviewed 88 pediatric patients with T2DM followed for at least 1 year at Seoul National University Bundang Hospital between 2013 and 2023. Remission was defined as a glycosylated hemoglobin (HbA1c) level less than 6.5% for at least 3 months after ceasing glucose-lowering pharmacotherapy.

RESULTS

Among 88 patients (60 males, 68.2%) diagnosed at an average age of 14.4±2.1 years, 19 patients (21.6%) achieved remission after a median duration of 1.4 years. The remission group had a larger proportion of males (89.5% vs. 62.3%, =0.024) and a lower urinary albumin-to-creatinine ratio (ACR) at diagnosis (=0.011). They also showed lower HbA1c levels at 1 year and more significant changes in HbA1c and body mass index (all <0.05). Higher urinary ACR levels correlated with a longer duration to achieve remission (hazard ratio, 0.928; =0.013). In three of the 19 remission patients (15.8%), recurrence occurred after a median of 1.5 years.

CONCLUSION

Among Korean youth with T2DM, 21.6% achieved remission after a median duration of 1.4 years. Those who experienced remission were predominantly male, had lower ACR at diagnosis, and had significant weight loss within the first year. Further investigation into the factors influencing remission and long-term outcomes is essential.